Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
暂无分享,去创建一个
Kenneth G. C. Smith | James C. Lee | P. MacAry | P. Lyons | J. Thumboo | E. McKinney | D. Kemeny | V. Jovanović | B. Teo | D. Jayne | K. Fong | S. Flint | A. Mak
[1] Shruti Sharma,et al. Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations. , 2015, Journal of autoimmunity.
[2] Kenneth G. C. Smith,et al. The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE. , 2015, Current pharmaceutical design.
[3] Virginia Pascual,et al. Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures , 2014, Arthritis & rheumatology.
[4] Oliver S. Burren,et al. A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes , 2014, Diabetes.
[5] Andreas Radbruch,et al. Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference? , 2013, PloS one.
[6] D. Absher,et al. Genome-Wide DNA Methylation Analysis of Systemic Lupus Erythematosus Reveals Persistent Hypomethylation of Interferon Genes and Compositional Changes to CD4+ T-cell Populations , 2013, PLoS genetics.
[7] L. Davis,et al. SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature , 2013, PloS one.
[8] K. Elkon,et al. Type I IFN system in the development and manifestations of SLE , 2012, Current opinion in rheumatology.
[9] A. Zychlinsky,et al. Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.
[10] D. Levy,et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. , 2012, Immunity.
[11] A. Oxenius,et al. Type‐I IFN drives the differentiation of short‐lived effector CD8+ T cells in vivo , 2012, European journal of immunology.
[12] Alvis Brazma,et al. A CD8 T cell transcription signature predicts prognosis in autoimmune disease , 2010, Nature Medicine.
[13] Yihong Yao,et al. Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus , 2009, Human genomics and proteomics : HGP.
[14] Kenneth G. C. Smith,et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis , 2009, Annals of the rheumatic diseases.
[15] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[16] R J Falk,et al. Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. , 2007, Kidney international.
[17] D. Sehy,et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. , 2006, Cytokine.
[18] A. Bertoletti,et al. Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells1 , 2005, The Journal of Immunology.
[19] Ion Gresser,et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. , 2002, Blood.
[20] G. V. van Seventer,et al. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. , 1998, Journal of immunology.
[21] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[22] H. L. Wright,et al. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy. , 2015, Rheumatology.